Results 81 to 90 of about 1,217,759 (290)

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo   +5 more
wiley   +1 more source

IgG GMC following a 2-dose primary series and a booster dose of PCV-7.

open access: yes, 2013
IgG antibody GMC for each of the 7 serotypes following vaccination with PCV-7, administered as a 2-dose primary series, given at 6- and 14-weeks of age, and a booster dose at 40 weeks of age. GMC were measured at baseline, after the first dose (Post PCV1)
Peter V. Adrian (198596)   +8 more
core   +1 more source

Heterologous booster dose against COVID-19: a narrative review

open access: yes, 2022
Vaccines against SARS-CoV-2 have been rapidly developed and deployed globally as a measure to combat COVID-19. These vaccines have been demonstrated to confer significant protection, but there have been reports of temporal decay in neutralising antibody ...
Picado, Apolinar, Sequeira, Samantha
core   +1 more source

Association Between Individualized Education for Kidney Replacement Therapy Modality Selection and Peritoneal Dialysis Initiation: A Cross‐Sectional Study

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito   +7 more
wiley   +1 more source

Safety comparison of mRNA, viral vector, and inactivated Covid-19 vaccines: incidence of adverse events following primary and booster doses among medical professionals in Malaysia

open access: yesBMC Infectious Diseases
Background This study aimed to examine adverse events following first, second, and booster doses of Covid-19 vaccines in Malaysia. Methods This was a prospective longitudinal cohort study conducted between September 2021 to September 2022. Recipients who
Rekha Prabhu   +5 more
doaj   +1 more source

Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3–4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination

open access: yesHeliyon
Background: Several countries have authorized a booster vaccine campaign to combat the spread of COVID-19. Data on persistence of booster vaccine‐induced immunity against new Omicron subvariants are still limited.
Suvichada Assawakosri   +18 more
doaj   +1 more source

Enteropathogenic E. coli shows delayed attachment and host response in human jejunum organoid‐derived monolayers compared to HeLa cells

open access: yesFEBS Letters, EarlyView.
Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi   +5 more
wiley   +1 more source

Efetividade das vacinas anti-hepatite B (DNA-Recombinante) em doadores de sangue [PDF]

open access: yes, 2004
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde. Programa de Pós-Graduação em Saúde Pública.O objetivo desse estudo foi estimar a efetividade das vacinas anti-hepatite B, produzidas através da tecnologia de ...
Petry, Andrea
core  

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

A Randomized Clinical Trial of a Fractional Low Dose of BNT162b2 Booster in Adults Following AZD1222

open access: yes, 2022
In the era of globally predominant omicron strains, a COVID-19 booster vaccine is needed. Our study aimed to evaluate the immunogenicity of a half-dose BNT162b2 booster after AZD1222 in healthy adults.
Watsamon Jantarabenjakul   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy